Chin Mark 4
4 · Iterum Therapeutics plc · Filed Jun 15, 2023
Insider Transaction Report
Form 4
Chin Mark
Director
Transactions
- Exercise/Conversion
Restricted Share Units
2023-06-15−15,853→ 0 total→ Ordinary Shares (15,853 underlying) - Exercise/Conversion
Ordinary Shares
2023-06-15+15,853→ 18,306 total
Footnotes (3)
- [F1]Restricted share units ("RSUs") converted into ordinary shares on a one-for-one basis upon vesting of the RSUs.
- [F2]On August 17, 2022 the Issuer effected a 1 for 15 reverse share split (the "Reverse Share Split"). The number of ordinary shares reported in this Form 4 have been adjusted to reflect the Reverse Share Split.
- [F3]On June 15, 2022, the reporting person was granted an award of 15,853 RSUs, which vested in full on June 15, 2023.